Shanda Asset Management Holdings’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,749
Closed -$1.45M 75
2021
Q2
$1.45M Hold
8,749
0.12% 59
2021
Q1
$1.34M Hold
8,749
0.11% 48
2020
Q4
$1.1M Hold
8,749
0.06% 48
2020
Q3
$887K Hold
8,749
0.06% 49
2020
Q2
$851K Hold
8,749
0.08% 68
2020
Q1
$727K Buy
8,749
+3,769
+76% +$368K 0.17% 30
2019
Q4
$554K Hold
4,980
0.11% 25
2019
Q3
$494K Hold
4,980
0.09% 28
2019
Q2
$494K Hold
4,980
0.09% 24
2019
Q1
$549K Buy
4,980
+2,000
+67% +$209K 0.09% 42
2018
Q4
$274K Buy
+2,980
New +$302K 0.05% 45

Other funds holding PRAH

Shanda Asset Management Holdings's PRAH Position: Q3 2021 in Review

Shanda Asset Management Holdings sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 8,749 shares — an estimated $1.45M sold.

Shanda Asset Management Holdings first reported a position in PRAH in Q4 2018 and held it in 11 quarters. The position peaked at $1.45M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Shanda Asset Management Holdings reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 8,749 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.45M.
  • Shanda Asset Management Holdings first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 11 quarters.
  • Shanda Asset Management Holdings's PRA Health Sciences, Inc. position peaked at $1.45M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.